This week’s View covers articles about whether there is an association between the use of fluoroquinolones and an increased risk of aortic or mitral regurgitation; whether a new classification of response, based on reverse remodeling and the clinical composite score, better predicts survival after cardiac resynchronization therapy; and the clinical profiles, discharge medical therapies, and in-hospital mortality among patients hospitalized for heart failure across the spectrum of kidney function.